Osteonecrose avascular pós COVID-19

Authors

  • Marcella Vilela Sampaio
  • Ana Clara Limeira da Cruz
  • Ana Clara Machado e Dias Correia
  • Anna Carolina Teixeira Lengruber Amaral
  • João Paulo Republicano da Silva Pinheiro
  • Juliana Vaz Ferreira
  • Leila Ismail Hamed Karaja
  • Luiz Fernando Arantes de Souza
  • Marcos César Brites Garcia
  • Maria Clara Cardoso Pereira
  • Maria Júlia Arbo
  • Roberta Pantoja

DOI:

https://doi.org/10.34119/bjhrv8n2-388

Keywords:

osteonecrose avascular, COVID-19, corticosteróides

Abstract

INTRODUÇÃO: A COVID-19 surgiu em 2019, na China, e logo se espalhou para os demais países, tornando-se uma pandemia. A doença era caracterizada por uma forte inflamação sistêmica, levando as equipes de saúde a prescreverem, cada vez mais, corticosteroides. Contudo, observou-se o aumento da incidência da osteonecrose avascular (NAV) , sendo possivelmente relacionado à pandemia de COVID-19. METODOLOGIA: Trata-se de uma revisão narrativa da literatura, realizada na base de dados PubMed/MEDLINE, com os descritores “Osteonecrosis”, “Avascular necrosis” AND “COVID-19”. Foram selecionados 19 artigos. DESENVOLVIMENTO: A fisiopatologia da COVID-19, com sua tempestade de citocinas e sua ativação da cascata de coagulação possibilita um estado de osteopenia, lesando osteoblastos e osteócitos e prolongando a vida dos osteoclastos. Para diminuir a exacerbação da COVID-19, utiliza-se corticosteróides (CS) das mais diversas formas. Contudo, o uso demasiado de CS pode levar à degradação óssea, sendo a principal causa não traumática de NAV. Assim, uma relação entre a pandemia de COVID-19 e o aumento de casos de NAV pode ser traçada. CONCLUSÃO: O aumento da incidência de NAV aparenta ter relação com a pandemia de COVID-19 e o seu uso exacerbado de corticosteróides. O diagnóstico e tratamento correto são essenciais para mitigar os efeitos da doença. Mais estudos são necessários.

References

ANNAM, Prathiba et al. Corticosteroids induced avascular necrosis OF HIP, a “long COVID-19” complication: CASE report. Annals of Medicine and Surgery, p. 104753, set. 2022.

BAIMUKHAMEDOV, Chokan et al. Osteonecrosis amid the COVID-19 pandemic. Rheumatology International, 25 abr. 2023.

Dhanasekararaja, P., Soundarrajan, D., Kumar, K.S. et al. Aggressive Presentation and Rapid Progression of Osteonecrosis of the Femoral Head After COVID-19. JOIO 56, 1259–1267, 2022.

EBRAHIMI CHAHAROM, Faegheh et al. Effects of corticosteroids on Covid-19 patients: a systematic review and meta-analysis on clinical outcomes. Pulmonary Pharmacology & Therapeutics, v. 72, p. 102107, fev. 2022.

HASSAN, Ahmed Abdelazim A.; KHALIFA, Ahmed A. Femoral head avascular necrosis in COVID-19 survivors: a systematic review. Rheumatology International, 20 jun. 2023.

INNEH, Adesuwa et al. COVID-19-Related bilateral avascular necrosis of the femoral head. Cureus, 24 ago. 2023.

Kashkosh, A., Peake, C. M., Narvani, A. A., IMAM, M. Spontaneous Avascular Necrosis of the Humeral Head Following COVID-19 Vaccination. The Archives of Bone and Joint Surgery, 11(2): 140-143, 2023.

MA, Shaolei et al. Efficacy and safety of systematic corticosteroids among severe COVID-19 patients: a systematic review and meta-analysis of randomized controlled trials. Signal Transduction and Targeted Therapy, v. 6, n. 1, 21 fev. 2021.

MIGLIORINI, Filippo et al. The pandemic is gone but its consequences are here to stay: avascular necrosis following corticosteroids administration for severe COVID-19. Journal of Orthopaedic Surgery and Research, v. 19, n. 1, 12 fev. 2024.

MUTHU, Sathish et al. Dose–Response meta-analysis of corticosteroid effects in SARS outbreak: A model for risk stratification and screening strategy for osteonecrosis of femoral head post-corticosteroid therapy for COVID-19. Life, v. 13, n. 4, p. 907, 29 mar. 2023.

PARASHER, Anant. COVID-19: current understanding of its pathophysiology, clinical presentation and treatment. Postgraduate Medical Journal, p. postgradmedj—2020-138577, 25 set. 2020.

PARIKH, Sarthak et al. Avascular necrosis as a sequela of COVID-19: a case series. Cureus, 23 fev. 2023.

SAKELLARIOU, Evangelos et al. A comprehensive review of covid-19-infection- and steroid-treatment-associated bone avascular necrosis: a multi-study analysis. Diagnostics, v. 14, n. 3, p. 247, 24 jan. 2024.

SAPRA, Leena et al. Long-term implications of COVID-19 on bone health: pathophysiology and therapeutics. Inflammation Research, 28 jul. 2022.

SHETTY, Gautam M. Double trouble—covid-19 and the widespread use of corticosteroids: are we staring at an osteonecrosis epidemic? Indian Journal of Orthopaedics, v. 56, n. 2, p. 226-236, 26 out. 2021.

SINHA, PritiR; MALLICK, Nitin; SAHU, RamjeeL. Avascular necrosis of the hip after the COVID-19 pandemic. Journal of Pharmacy And Bioallied Sciences, v. 15, n. 5, p. 661, 2023.

SOOD, Dr Anubhuti et al. Post-COVID steroid induced avascular necrosis of the jaw: emerging challenge in India. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, set. 2022.

VELCHOV, Vensan et al. Corticosteroid-Associated avascular necrosis of the femoral head in patients with severe COVID-19: a single-center study. Medical Science Monitor, v. 29, 21 jun. 2023.

YOON, Byung-Ho et al. Etiologic classification criteria of ARCO on femoral head osteonecrosis part 1: glucocorticoid-associated osteonecrosis. The Journal of Arthroplasty, v. 34, n. 1, p. 163-168.e1, jan. 2019.

Published

04/29/2025

How to Cite

SAMPAIO, M. V.; CRUZ, A. C. L. da; CORREIA, A. C. M. e D.; AMARAL, A. C. T. L.; PINHEIRO, J. P. R. da S.; FERREIRA, J. V.; KARAJA, L. I. H.; SOUZA, L. F. A. de; GARCIA, M. C. B.; PEREIRA, M. C. C.; ARBO, M. J.; PANTOJA, R. Osteonecrose avascular pós COVID-19. Brazilian Journal of Health Review, [S. l.], v. 8, n. 2, p. e79331, 2025. DOI: 10.34119/bjhrv8n2-388. Disponível em: https://ojs.brazilianjournals.com.br/ojs/index.php/BJHR/article/view/79331. Acesso em: 17 oct. 2026.

Issue

Section

Original Papers